Composition For Preventing Or Treating Osteoarthritis, Comprising Mesenchymal Stem Cell Expressing Tumor Necrosis Factor Inducible Gene 6

Abstract: The present application relates to a use for cartilage regeneration and/or use for osteoarthritis treatment of a mesenchymal stem cell expressing TSG-6 protein. The present application provides a composition for cartilage regeneration and a pharmaceutical composition for osteoarthritis treatment, comprising a mesenchymal stem cell expressing TSG-6 protein as an active ingredient. The composition for cartilage regeneration and/or the pharmaceutical composition for osteoarthritis treatment provided by the present application can increase collagen expression of cartilage cells, reduce inflammation, and restore the cartilage structure.

Patent Information

Applicants

Inventors

Specification

Documents